These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4623684)

  • 1. The changing pattern of diseases associated with M components.
    Pruzanski W; Ogryzlo MA
    Med Clin North Am; 1972 Mar; 56(2):371-89. PubMed ID: 4623684
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulin disturbances and their clinical significance.
    Solomon A; McLaughlin CL
    Med Clin North Am; 1973 Mar; 57(2):499-516. PubMed ID: 4632920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunochemical studies of monoclonal gammapathies: anachronism or research prospectives?].
    Gergely J; Eckhardt S
    Orv Hetil; 1975 Jul; 116(27):1563-6. PubMed ID: 806867
    [No Abstract]   [Full Text] [Related]  

  • 4. The frequency distribution of heavy chain classes and light chain types of 1,000 monoclonal immunoglobulins.
    Creyssel R; Gibaud A; Cordier JF; Boissel JP
    Biomedicine; 1975 Jan; 22(1):41-8. PubMed ID: 810190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunoglobulins: a review.
    Martin NH
    J Clin Pathol; 1969 Mar; 22(2):117-31. PubMed ID: 4180999
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma cell dyscrasias.
    Barlogie B; Alexanian R; Jagannath S
    JAMA; 1992 Nov; 268(20):2946-51. PubMed ID: 1433713
    [No Abstract]   [Full Text] [Related]  

  • 7. The immune system: immunoglobulin abnormalities.
    Dharan M
    Am J Nurs; 1976 Oct; 76(10):1626-8. PubMed ID: 823822
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunoproliferative diseases. Immunochemical classification and presentation of a case of micromolecular myleoma].
    Piaserico PL; Salmeri G; Dalla Pria AF; Sandri R; Pivetta G
    G Batteriol Virol Immunol; 1974; 67(1-6):147-72. PubMed ID: 4217302
    [No Abstract]   [Full Text] [Related]  

  • 9. [The structure of normal and pathological human immunoglobulins].
    Seligmann M
    Presse Med (1893); 1967 Oct; 75(45):2243-4. PubMed ID: 4168455
    [No Abstract]   [Full Text] [Related]  

  • 10. B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.
    Seligmann M; Preud'Homme JL; Brouet JC
    Transplant Rev; 1973; 16():85-113. PubMed ID: 4204588
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of the monoclonal gammopathies. 1.
    Maldonado JE; Kyle RA; McDuffie FC; Linman JW
    Postgrad Med; 1973 Jun; 53(7):102-6. PubMed ID: 4122509
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal immunoglobulins.
    Franklin EC
    Ann Clin Lab Sci; 1980; 10(3):181-6. PubMed ID: 6772084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biochemistry of monoclonal immunoglobulins. A contribution to the antibody problem.
    Hilschmann N; Ponstingl H; Schwarz J; Reichel W; Baczko K; Braun D; Hess M; Watanabe S; Uter L; Barnikol HU
    Hamatol Bluttransfus; 1970; 9():149-65. PubMed ID: 4101215
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
    Kraj M; Maj S; Rostkowska J
    Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraproteinemic neuropathy.
    Kwan JY
    Neurol Clin; 2007 Feb; 25(1):47-69. PubMed ID: 17324720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoglobulin E in patients with chronic lymphocytic leukaemia, multiple myeloma and morbus Waldenström (author's transl)].
    Schwarz S; Gabl F; Pastner D; Huber H; Braunsteiner H
    Z Immunitatsforsch Exp Klin Immunol; 1974 Dec; 148(3):196-207. PubMed ID: 4283033
    [No Abstract]   [Full Text] [Related]  

  • 17. Technical aspects of the detection and characterization of immunoglobulin dyscrasis.
    Conway BP
    Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of antiserum against myeloma cells.
    Cawley LP; Goodwin WL; Minard BJ
    Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte response to phytohemagglutinin (PHA) in in vitro culture and quantitative and qualitative changes in serum immunoglobulins in patients with plasma-cell myeloma.
    Traczyk Z; Cieśluk S; Snigurowicz J
    Arch Immunol Ther Exp (Warsz); 1975; 23(1):105-11. PubMed ID: 803827
    [No Abstract]   [Full Text] [Related]  

  • 20. Current views on immunoglobulin abnormalities and B cell proliferations.
    Seligmann M; Clauvel JP
    Adv Nephrol Necker Hosp; 1977; 7():237-59. PubMed ID: 96675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.